Nuvectra Corp. | Mutual Funds

Mutual Funds that own Nuvectra Corp.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
Vanguard Total Stock Market Index Fund
383,563
2.69%
29,100
0%
07/31/2018
iShares Russell 2000 ETF
291,047
2.04%
-156
0.01%
09/06/2018
Hodges Small Intrinsic Value Fund
250,000
1.75%
50,000
6.57%
03/31/2018
DFA US Small Cap Portfolio
188,117
1.32%
8,644
0.02%
04/30/2018
Vanguard Extended Market Index Fund
156,996
1.1%
0
0.01%
07/31/2018
iShares Russell 2000 Growth ETF
136,110
0.95%
0
0.03%
09/06/2018
DFA US Targeted Value Portfolio
120,696
0.85%
-11,325
0.02%
04/30/2018
Russell US Small Cap Equity Fund
120,058
0.84%
120,058
0.13%
04/30/2018
Driehaus Micro Cap Growth Fund
117,911
0.83%
4,443
0.56%
06/30/2018
DFA US Micro Cap Portfolio
115,755
0.81%
0
0.03%
04/30/2018

About Nuvectra

View Profile
Address
5830 Granite Parkway
Plano Texas 75024
United States
Employees -
Website http://www.nuvectramed.com
Updated 07/08/2019
Nuvectra Corp. engages in the development and commercialization of neurostimulation technology platform for treatment of various disorders through stimulation of tissues associated with the nervous systems. It operates through Nuvectra, and NeuroNexus segments. The Nuvectra segmeng is a neurostimulation company committed to helping physicians improve the lives of people with chronic conditions.